| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $39.6M | +8.2% |
| SG&A Expense | $26.5M | -1.4% |
| Operating Income | -$66.1M | -4.2% |
| Interest Expense | $5.1M | +374.8% |
| Pre-tax Income | -$67.9M | -7.3% |
| Income Tax | $0 | -100.0% |
| Net Income | -$34.0M | -11.1% |
| EPS (Basic) | -$1.33 | -3.9% |
| EPS (Diluted) | -$1.33 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.9M | -78.3% |
| Current Assets | $50.8M | -49.6% |
| Total Assets | $57.9M | -46.4% |
| Current Liabilities | $8.0M | +65.9% |
| Long-term Debt | $30.0M | +0.0% |
| Total Liabilities | $32.5M | -4.6% |
| Stockholders' Equity | $12.9M | -65.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$51.2M | -10.1% |
| Capital Expenditures | $1.2M | -24.1% |
| Investing Cash Flow | $29.9M | +141.2% |
| Financing Cash Flow | $233K | -99.2% |
| Free Cash Flow | -$52.5M | -9.0% |
| -3.9% |